首页|FLOT方案治疗晚期胃癌患者的疗效

FLOT方案治疗晚期胃癌患者的疗效

Efficacy of FLOT regimen in the treatment of advanced gastric cancer

扫码查看
目的 探讨FLOT方案治疗晚期胃癌患者的疗效.方法 将106例晚期胃癌患者根据化疗方案的不同分为FLOT组和SOX组,每组53例.FLOT组患者采用FLOT化疗方案,SOX组患者采用SOX化疗方案.比较两组患者临床疗效、炎性因子[C反应蛋白(CRP)、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、IL-10]、肿瘤标志物[癌胚抗原(CEA)、糖类抗原(CA)19-9、CA125、CA72-4]、营养状态指标[总蛋白(TP)、转铁蛋白(TRF)、前白蛋白(PAB)、白蛋白(ALB)]、癌因性疲乏[Piper疲乏修正量表(RPFS)]与不良反应发生情况.结果 FLOT组患者的客观缓解率(ORR)高于SOX组,脱发发生率低于SOX组,差异均有统计学意义(P<0.05).化疗后,两组患者CRP、IL-6、IL-10、TNF-α、TRF、ALB、PAB、TP 水平均升高,CEA、CA19-9、CA125、CA72-4 水平均降低,FLOT 组患者 CRP、IL-6、TNF-α、CEA、CA19-9、CA125、CA72-4 水平均低于 SOX 组,IL-10、TRF、ALB、PAB、TP 水平均高于SOX组,差异均有统计学意义(P<0.05).化疗后,FLOT组患者RPFS各维度评分均明显低于SOX组,差异均有统计学意义(P<0.01).结论 FLOT化疗方案治疗晚期胃癌患者疗效更为理想,可降低血清肿瘤标志物水平,减轻患者癌因性疲乏,改善患者营养状态,且安全性较好.
Objective To investigate the efficacy of FLOT regimen in patients with advanced gastric cancer.Method A total of 106 patients with advanced gastric cancer were divided into FLOT group and SOX group according to differ-ent chemotherapy regimens,with 53 cases in each group.FLOT group was treated with FLOT chemotherapy,SOX group was treated with SOX chemotherapy.The clinical efficacy,inflammatory factors[C-reactive protein(CRP),tumor necrosis factor(TNF)-α,interleukin(IL)-6,IL-10],tumor markers[carcinoembryonic antigen(CEA),carbohydrate anti-gen(CA)19-9,CA125,CA72-4],nutritional status indicators[total protein(TP),transferiron(TRF),prealbumin(PAB),albumin(ALB)],cancer-induced fatigue[revised Piper fatigue scale(RPFS)]and adverse reactions were compared be-tween the two groups.Result The objective response rate(ORR)in FLOT group was higher than that in SOX group,and the incidence of alopecia was lower than that in SOX group,the differences were statistically significant(P<0.05).After chemotherapy,the levels of CRP,IL-6,IL-10,TNF-α,TRF,ALB,PAB and TP increased,while the levels of CEA,CA19-9,CA125 and CA72-4 decreased in both groups,the levels of CRP,IL-6,TNF-α,CEA,CA19-9,CA125 and CA72-4 in FLOT group were lower than those in SOX group,while the levels of IL-10,TRF,ALB,PAB and TP were higher than those in SOX group,the differences were statistically significant(P<0.05).After chemotherapy,the scores of each dimension of RPFS in FLOT group were significantly lower than those in SOX group,the differences were statisti-cally significant(P<0.01).Conclusion FLOT chemotherapy is more effective in the treatment of advanced gastric can-cer patients,can reduce the level of serum tumor markers and cancer-related fatigue,improve the nutritional status,and has good safety.

advanced gastric cancerFLOT regimenefficacytumor markernutritional statuscancer-induced fatigue

田凯琴、郭峰、韦侃侃、魏宣宣

展开 >

郑州大学第一附属医院西药调剂室,郑州 450000

晚期胃癌 FLOT方案 疗效 肿瘤标志物 营养状态 癌因性疲乏

河南省医学科技攻关计划(联合共建)项目

LHGJ20191495

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(11)
  • 10